Live updates

Teck: Copper kills up to 99.9% of bacteria on transit surfaces

Copper trial shows the material kills up to 99.9% of bacteria on transit surfaces

An antimicrobial copper trial on Metro Vancouver transit supported by Teck in partnership with Translink and Vancouver Coastal Health shows clear health benefits, with copper effective at killing bacteria on high-touch transit surfaces.

Based on sample-testing performed on transit and in a lab, the trial concludes that select copper products on transit are durable and kill up to 99.9% of all bacteria within one hour of the bacteria’s contact with the surface.

"These results reinforce the effectiveness of copper’s antimicrobial properties in killing germs and contributing to better public health. Through our Copper & Health program, Teck has been working with healthcare professionals, academia and others to help make communities safer with copper. We look forward to continuing to work with TransLink and all the partners and working to expand the use of copper on public high-touch surfaces to protect human health.”

— Don Lindsay, President and CEO, Teck

Further details on Teck Resources' Copper & Health program can be found online at www.copperstopsthespread.ca.

Novo Nordisk: Focusing on diabetes prevention

Novo Nordisk is teaming up with the University of Toronto with a $32.5 million investment to establish the Novo Nordisk Network for Healthy Populations.

The network will focus on new ways to support healthier urban populations and will draw on U of T’s leading expertise in public health research and education programmes to impact the global fight against diabetes and other serious chronic diseases.

Cognizant: Advancing corporate social responsibility

Cognizant has announced a new five-year $250 million effort to advance economic mobility, educational opportunity, diversity and inclusion, and health and well-being in communities around the world.

Building on its longstanding investment in corporate social responsibility, Cognizant will work to create stronger, healthier, and more inclusive communities as they emerge from the COVID-19 pandemic.

JD.com: Closed-loop service for rare diseases

JD Health, the healthcare arm of JD.com, launched its national care centre and dedicated fund for rare diseases ahead of Rare Disease Day over the weekend.

From diagnosis, treatment to medication, JD Health is doing our best to create a closed-loop service for patients with rare diseases.

— Lijun Xin, CEO of JD Health

Leveraging its advantages in telemedicine technology, resource integration, and public engagement, the platform is committed to improving the accessibility of orphan products/drugs and medical services for patients, and improving society’s awareness and inclusiveness of people affected by rare diseases.

Read more here.